Lung Cancer Research: Articles & Explainers
Plain-language explainers on lung cancer biology, biomarkers, treatment categories, and how to read clinical trial research — including guides to our own free Research Progress Tracker tool.
What Is the Lung Cancer Research Progress Tracker? How Our Free Tool Works
A plain-language explanation of how the free Lung Cancer Research Progress Tracker works, what data it uses, and what it does and doesn't do.
Read More →How to Read Your Research Momentum Score: A Guide to the Lung Cancer Research Progress Tracker
How the Research Momentum Score on the Lung Cancer Research Progress Tracker is calculated and what it does and doesn't tell you.
Read More →Lung Cancer Research Progress Tracker vs. Clinical Trial Matching Services: What's the Difference
How the free Lung Cancer Research Progress Tracker differs from clinical trial matching services like those offered by patient advocacy nonprofits.
Read More →What Is Non-Small Cell Lung Cancer (NSCLC)? A Plain-Language Guide
A plain-language explanation of non-small cell lung cancer (NSCLC), its main subtypes, and how it differs from small cell lung cancer.
Read More →What Is Small Cell Lung Cancer (SCLC)? Key Facts
Key facts about small cell lung cancer (SCLC), including how common it is, how it's typically staged, and current research directions.
Read More →EGFR Mutation in Lung Cancer Explained
What an EGFR mutation in lung cancer means, why it matters for treatment, and the difference between classical and atypical EGFR mutations.
Read More →ALK-Positive Lung Cancer: What the Research Shows
What ALK-positive lung cancer means, how common it is, and what current research shows about this NSCLC subtype.
Read More →KRAS G12C Mutation in Lung Cancer: From 'Undruggable' to Targetable
How the KRAS G12C mutation in lung cancer went from being considered undruggable to having FDA-approved targeted therapies.
Read More →What Is Immunotherapy for Lung Cancer? How It Works
A plain-language explanation of how immunotherapy for lung cancer works and why it represented a major shift in cancer treatment research.
Read More →What Is Targeted Therapy for Lung Cancer?
How targeted therapy for lung cancer works, and how it differs from chemotherapy and immunotherapy.
Read More →What Are Antibody-Drug Conjugates (ADCs)?
A plain-language explanation of antibody-drug conjugates (ADCs), a fast-growing category of lung cancer research.
Read More →What Is a Bispecific Antibody? Explained for Lung Cancer Research
How bispecific antibodies work in lung cancer research and why they represent a growing treatment category.
Read More →Understanding PD-L1 Testing in Lung Cancer
What PD-L1 testing measures in lung cancer, how it's used, and its limitations as a predictor of immunotherapy response.
Read More →What Is Tumor Mutational Burden (TMB)?
What tumor mutational burden (TMB) means, how it's measured, and how it relates to immunotherapy response in lung cancer.
Read More →Lung Cancer in Never-Smokers: What Research Says
What current research says about lung cancer in never-smokers, including risk factors, biology, and rising incidence trends.
Read More →Why Is Lung Cancer Rising in Non-Smokers?
The leading research explanations for why lung cancer rates in non-smokers appear to be rising, including air pollution and radon.
Read More →Radon and Lung Cancer: What You Should Know
What radon gas is, how it's linked to lung cancer, and why it's considered a significant risk factor even for non-smokers.
Read More →Air Pollution and Lung Cancer Risk: The Research
What current research shows about the link between air pollution, particularly fine particulate matter (PM2.5), and lung cancer risk.
Read More →Low-Dose CT Screening for Lung Cancer: Who Qualifies?
How low-dose CT (LDCT) lung cancer screening works, the mortality benefit shown in trials, and general eligibility criteria.
Read More →Understanding Lung Cancer Stages: I Through IV
A plain-language guide to how lung cancer stages I through IV are generally defined and why staging matters for research and treatment planning.
Read More →What Is Neoadjuvant Therapy for Lung Cancer?
What neoadjuvant therapy means in lung cancer treatment, and why it's an active area of current clinical trial research.
Read More →What Is Adjuvant Therapy After Lung Cancer Surgery?
What adjuvant therapy means in lung cancer treatment, and why it's used after surgical removal of a tumor.
Read More →Liquid Biopsy for Lung Cancer: How It Works
What liquid biopsy testing is, how it detects circulating tumor DNA, and why it's an active area of lung cancer research.
Read More →Understanding Clinical Trial Phases (I, II, III, IV)
A plain-language explanation of what clinical trial phases I through IV mean in cancer research.
Read More →What Does 'Median Overall Survival' Mean in Cancer Research?
What median overall survival means as a clinical trial statistic, and how to interpret it responsibly.
Read More →What Is Progression-Free Survival?
What progression-free survival (PFS) means as a clinical trial outcome measure and how it differs from overall survival.
Read More →Understanding Lung Cancer Survival Rate Statistics
How to interpret lung cancer five-year survival rate statistics, including why they vary so dramatically by stage.
Read More →What Is a Basket Trial?
What a 'basket trial' is in cancer research and why this trial design has become more common in lung cancer studies.
Read More →What Is a Master Protocol Trial? Lung-MAP Explained
What a master protocol clinical trial is, using Lung-MAP as an example of this collaborative research design in lung cancer.
Read More →STK11 and KEAP1 Mutations: Why They Matter in Lung Cancer
What STK11 and KEAP1 mutations are in lung cancer, and why they're associated with weaker immunotherapy response.
Read More →Squamous vs. Non-Squamous NSCLC: What's the Difference
The difference between squamous and non-squamous non-small cell lung cancer (NSCLC), and why the distinction matters for treatment planning.
Read More →Understanding FDA Accelerated Approval for Cancer Drugs
What the FDA's accelerated approval pathway means for new cancer drugs, and how it differs from standard full approval.
Read More →What Is Circulating Tumor DNA (ctDNA)?
What circulating tumor DNA (ctDNA) is, how it's detected, and how it's used in lung cancer research and monitoring.
Read More →